Acorah Software Products - Accounts Production19.2.450truetrue31 May 20241 June 2023falsetrueNo description of principal activity1 June 202431 May 202531 May 202515705021Mr Sunil Shahiso4217:GBPiso4217:EURiso4217:USDxbrli:sharesxbrli:purexbrli:pure157050212024-05-31157050212025-05-31157050212024-06-012025-05-3115705021frs-bus:PrivateLimitedCompanyLtd2024-06-012025-05-3115705021frs-bus:FilletedAccounts2024-06-012025-05-3115705021frs-bus:Micro-entities2024-06-012025-05-3115705021frs-bus:EntityHasNeverTraded2024-06-012025-05-3115705021frs-bus:AuditExempt-NoAccountantsReport2024-06-012025-05-3115705021frs-bus:Director12024-06-012025-05-31157050212023-05-31157050212024-05-31157050212023-06-012024-05-31
Registered number: 15705021
Max Biotech Diabetes Limited
Unaudited Financial Statements
For The Year Ended 31 May 2025
Waterfords Europe Limited t/a Jon Avol Waterfords
Max Biotech Diabetes Limited
Balance Sheet
As At 31 May 2025
Balance Sheet
Registered number: 15705021
2025
2024
£
£
Current assets
100
100
NET CURRENT ASSETS
100
100
TOTAL ASSETS LESS CURRENT LIABILITIES
100
100
NET ASSETS
100
100
CAPITAL AND RESERVES
100
100
Notes
1.General Information
Max Biotech Diabetes Limited is a private company, limited by shares, incorporated in England & Wales, registered number 15705021. The registered office is 20 Farquhar Road, Edgbaston, Birmingham, B15 3RB.
2.Average Number of Employees
Average number of employees, including directors, during the year was: 11 (2024: 1)
111
For the year ending 31 May 2025 the company was entitled to exemption from audit under section 480 of the Companies Act 2006 relating to dormant companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.